Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherman

Showing results (601-610 of 1,108) with videos related to

Pageof 111
Sort By:
Human Reproduction (Oxford, England)|March 4, 2008
Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary studyJ Rohr, E G Allen, K Charen, et al.
Instructional Course Lectures|January 13, 2021
Cartilage Disease of the Patellofemoral Joint: Realignment, Restoration, ReplacementPeters Otlans, Christian Lattermann, Seth L Sherman, et al.
Arthroscopy, Sports Medicine, and Rehabilitation|December 29, 2022
Transtibial Repair of Lateral Meniscus Posterior Root Tears Improves Contact Biomechanics in Pediatric CadaversAnshal Gupta, Mark Sanchez, Hunter W Storaci, et al.
Molecular Biology and Evolution|April 16, 2004
Evolutionary dynamics and preferential expression of homeologous 18S-5.8S-26S nuclear ribosomal genes in natural and artificial glycine allopolyploidsSimon Joly, Jason T Rauscher, Susan L Sherman-Broyles, et al.
Molecular Endocrinology (Baltimore, Md.)|January 11, 2000
Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibodyD L Clemm, L Sherman, V Boonyaratanakornkit, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot studyB J Dezube, M L Sherman, J L Fridovich-Keil, et al.
American Journal of Human Genetics|October 7, 2009
Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNABradford Coffee, Krayton Keith, Igor Albizua, et al.
Oncogene|April 13, 2010
The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancerC Richard, C Lanner, S N Naryzhny, et al.
Cartilage|September 11, 2020
Microfracture for the Treatment of Symptomatic Cartilage Lesions of the Knee: A Survey of International Cartilage Regeneration & Joint Preservation SocietyJesus Medina, Ignacio Garcia-Mansilla, Peter D Fabricant, et al.
Cancer Treatment Reports|November 1, 1987
Inadequacy of predicted creatinine clearance as guide to chemotherapyD F McDermott, A Galindo, R L Sherman, et al.
Pageof 111

Showing results (601-610 of 1,108) with videos related to

Sort By:
Pageof 111
Human Reproduction (Oxford, England)|March 4, 2008
Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary studyJ Rohr, E G Allen, K Charen, et al.
Instructional Course Lectures|January 13, 2021
Cartilage Disease of the Patellofemoral Joint: Realignment, Restoration, ReplacementPeters Otlans, Christian Lattermann, Seth L Sherman, et al.
Arthroscopy, Sports Medicine, and Rehabilitation|December 29, 2022
Transtibial Repair of Lateral Meniscus Posterior Root Tears Improves Contact Biomechanics in Pediatric CadaversAnshal Gupta, Mark Sanchez, Hunter W Storaci, et al.
Molecular Biology and Evolution|April 16, 2004
Evolutionary dynamics and preferential expression of homeologous 18S-5.8S-26S nuclear ribosomal genes in natural and artificial glycine allopolyploidsSimon Joly, Jason T Rauscher, Susan L Sherman-Broyles, et al.
Molecular Endocrinology (Baltimore, Md.)|January 11, 2000
Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibodyD L Clemm, L Sherman, V Boonyaratanakornkit, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot studyB J Dezube, M L Sherman, J L Fridovich-Keil, et al.
American Journal of Human Genetics|October 7, 2009
Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNABradford Coffee, Krayton Keith, Igor Albizua, et al.
Oncogene|April 13, 2010
The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancerC Richard, C Lanner, S N Naryzhny, et al.
Cartilage|September 11, 2020
Microfracture for the Treatment of Symptomatic Cartilage Lesions of the Knee: A Survey of International Cartilage Regeneration & Joint Preservation SocietyJesus Medina, Ignacio Garcia-Mansilla, Peter D Fabricant, et al.
Cancer Treatment Reports|November 1, 1987
Inadequacy of predicted creatinine clearance as guide to chemotherapyD F McDermott, A Galindo, R L Sherman, et al.
Pageof 111